Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer

In women with hormone receptor-positive (HR+) breast cancer, the risk of distant recurrence and death persists for at least 20 years from diagnosis. The risk of late mortality in men with HR+ breast cancer has not been reported.